Online Inquiry
Cat.#: ACPP-1273
| Despition | BTB/POZ domain-containing protein 7 Blocking Peptide for Immmunodepletion, Competition Assay |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1355 | MERTK Blocking Peptide (AC1355) | 250 µg | inquiry |
| ACPP-1286 | Bestrophin 2 Blocking Peptide (AC1286) | 250 µg | inquiry |
| ACPP-1594 | Human CCM2 Protein (AC1594) | 2 µg | inquiry |
| ACPP-1450 | Human BMP13 Protein (AC1450) | 10 µg | inquiry |
| ACPP-1629 | Human GDF7 Protein (AC1629) | 2 µg | inquiry |
| ACPP-1204 | P2Y1 Blocking Peptide (AC1204) | 250 µg | inquiry |
| ACPP-1004 | Synthetic Nanodisc Human GPCR GPR20 Protein (AC1004) | 10 µg | inquiry |
| ACPP-1416 | Human VAMP1 Protein (AC1416) | 20 µg | inquiry |
| ACPP-1624 | Human EFNA1 Protein (AC1624) | 5 µg | inquiry |
| ACPP-1829 | Human SNAPIN Protein (AC1829) | 10 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.